RESUMO
p53 mutation is a common genetic change in human cancers, but the clinical significance is controversial. We studied 68 patients and estimate the prevalence of intestinal metaplasia of cardia (IMC), Barrett's esophagus (BE), and p53 protein overexpression, and described molecular alterations of p53 gene exons 5 to 8. Immunohistochemical analysis showed positive p53 in 56.1-39.1% (IMC) and 60.9% (BE). Molecular analysis showed 36.6% altered cases in exon 5 and 9.8% in exon 7. In conclusion, p53 protein overexpression is common in IMC and BE. The molecular alterations observed may be due to LOH, genomic instability or other unknown alteration.
Assuntos
Esôfago de Barrett/genética , Cárdia/patologia , Esofagite/genética , Perfilação da Expressão Gênica , Genes p53/genética , Proteína Supressora de Tumor p53/biossíntese , Adulto , Idoso , Idoso de 80 Anos ou mais , Análise Mutacional de DNA , Feminino , Instabilidade Genômica , Humanos , Imuno-Histoquímica , Perda de Heterozigosidade , Masculino , Metaplasia , Pessoa de Meia-Idade , Regulação para CimaRESUMO
Mucopolysaccharidosis type VI, or Maroteaux-Lamy syndrome, is an autosomal recessive disease caused by the deficiency of arylsulfatase B (ARSB; N-acetyl-galactosamine-4-sulfatase, E.C.3.1.6.12), which is involved in the stepwise degradation of dermatan sulfate and chondroitin sulfate. The deficiency of this enzyme causes storage in the lysozomes and excretion in the urine of partially degraded dermatan sulfate. Twenty patients with MPSVI were analyzed, including 2 siblings. Genomic DNA from patients was extracted and amplified by PCR followed by analysis by single-strand conformation polymorphism (SSCP), which detects altered patterns in the single-stranded DNA. Amongst the patients analyzed for exon 8 of the ARSB gene, 5 patients presented an altered band pattern when compared to controls. After sequencing, we have detected a 23-bp deletion, extending from nucleotides 1,533 to 1,555, causing a frameshift and changing 2 amino acids before creating a premature stop codon at amino acid 514.
Assuntos
Mutação da Fase de Leitura , Mucopolissacaridose VI/genética , N-Acetilgalactosamina-4-Sulfatase/genética , Brasil , Estudos de Casos e Controles , Humanos , Reação em Cadeia da Polimerase/métodos , Polimorfismo Conformacional de Fita Simples , Análise de Sequência de DNARESUMO
BACKGROUND: The importance of metabolic factors in neural tube defects (NTDs) has been the focus of many investigations. Several authors have suggested that abnormalities in homocysteine metabolism, such as hyperhomocysteinemia, folate deficiency, and low vitamin B12, may be responsible for these malformations and that both nutritional factors and genetic abnormalities are associated with them. METHODS: We conducted a case-control study to investigate the influence of biochemical and genetic factors in NTDs in infants in southern Brazil. Levels of folate, vitamin B12, total homocysteine (t-Hcy) and the 677C>T and 1298A>C polymorphisms of the MTHFR gene were analyzed in 41 NTD child-mother pairs and 44 normal child-mother control pairs. RESULTS: Subjects in the case group had a higher mean blood folate level than those in the control group. The level of vitamin B12 was lower in mothers in the NTD group than in control mothers (p = 0.004). The level of t-Hcy was not different in the two groups, but t-Hcy and vitamin B12 were correlated (p = 0.002). There was no difference in the genotype distribution for 677C>T and 1298A>C polymorphisms of MTHFR in the case and control pairs. The level of t-Hcy was correlated with 677TT. CONCLUSIONS: Despite the small sample in this study, we suggest that low vitamin B12 and, consequently, hyperhomocysteinemia are important risk factors for NTDs in our population.
Assuntos
Metilenotetra-Hidrofolato Redutase (NADPH2)/metabolismo , Defeitos do Tubo Neural/genética , Polimorfismo Genético , Adolescente , Adulto , Brasil , Criança , Pré-Escolar , Feminino , Ácido Fólico/sangue , Homocisteína/sangue , Humanos , Lactente , Masculino , Metilenotetra-Hidrofolato Redutase (NADPH2)/genética , Defeitos do Tubo Neural/enzimologia , Defeitos do Tubo Neural/metabolismo , Vitamina B 12/sangueRESUMO
In this study we have investigated a group of 29 Brazilian patients, who had been diagnosed with the lysosomal storage disorder, Mucopolysaccharidosis type I (MPS-I). MPS I is caused by a deficiency in the lysosomal hydrolase, alpha-L-iduronidase. Ninety percent of the MPS I patients in this study were genotyped and revealed 10 recurrent and thirteen novel IDUA gene mutations. Eight of these new mutations and three common mutations W402X, P533R, and R383H were individually expressed in CHO-K1 cells and analyzed for alpha-L-iduronidase protein and enzyme activity. A correlation was observed between the MPS I patient clinical phenotype and the associated mutant alpha-L-iduronidase protein/enzyme activity expressed in CHO-K1 cells. This was the first time that Brazilian MPS I patients had been thoroughly analyzed and highlighted the difficulties of mutation screening and clinical phenotype assessment in populations with high numbers of unique mutations.
Assuntos
Iduronidase/genética , Mucopolissacaridose I/genética , Animais , Western Blotting , Células CHO , Cricetinae , DNA/química , DNA/genética , Análise Mutacional de DNA , Regulação Enzimológica da Expressão Gênica , Humanos , Iduronidase/metabolismo , Mucopolissacaridose I/enzimologia , Mutação , Polimorfismo Conformacional de Fita Simples , TransfecçãoRESUMO
As mucopolissacaridoses (MPS) constituem, devido às suas características bioquímicas, genéticas e clínicas, um grupo grande e heterogêneo dentro das doenças lisôssomicas de depósito (LSD), e säo causadas pela deficiência de enzimas específicas que säo responsáveis pela quebra de gicosaminoglicanos (GAGs) em passos diferentes da sua rota de degradaçäo. Sendo as MPS responsáveis por aproximadamente 32 por cento dos erros inatos do metabolismo (EIM) e 54 por cento das LSD identificadas em nosso laboratório (Laboratório Regional dos Erros Inatos do Metabolismo (RLIEM), Serviço de Genética Médica, Hospital de Clínicas de Porto Alegre), que é um centro de referência para o diagnóstico de LSD no Brasil, nós decidimos implantar uma rotina para detecçäo e o diagnóstico diferencial de MPS em pacientes com características clínicas sugestivas deste grupo de doenças.
Assuntos
Humanos , Lactente , Pré-Escolar , Criança , Doenças por Armazenamento dos Lisossomos , Mucopolissacaridoses/diagnóstico , Diagnóstico Diferencial , Testes Diagnósticos de Rotina , Enzimas/deficiência , Glicosaminoglicanos/metabolismo , Glicosaminoglicanos/urinaRESUMO
Friedreich ataxia (FRDA), the most commom autosomal recessive ataxia, is caused in 94 per cent of cases by homozygous expansions of an unstable GAA repeat localised in intron 1 of the X25 gene. We have investigated this mutation in five Brazilian patients: four with typical FRDA findings and one patient with atypical manifestations, who was considered to have some other form of cerebellar ataxia with retained reflexes. The GAA expansion was detected in all these patients. The confirmation of FRDA diagnosis in the atypical case may be pointing out, as in other reports, that clinical spectrum of Friedreich's ataxia is broader than previously recognised and includes cases with intact tendon reflexes.
Assuntos
Humanos , Masculino , Feminino , Criança , Adulto , Ataxia de Friedreich/diagnóstico , Brasil , Ataxia de Friedreich/genética , Ataxia de Friedreich/fisiopatologia , Reação em Cadeia da Polimerase , Expansão das Repetições de TrinucleotídeosRESUMO
The mucopolysaccharidoses (MPS) are a heterogeneous group of inborn errors of lysosomal glycosaminoglycan (GAG) metabolism. The importance of this group of disorders among the inborn errors of metabolism led us to report 19 cases. METHOD: We performed clinical, radiological, and biochemical evaluations of the suspected patients, which allowed us to establish a definite diagnosis in 19 cases. RESULTS: Not all patients showed increased GAG levels in urine; enzyme assays should be performed in all cases with strong clinical suspicion. The diagnosis was made on average at the age of 48 months, and the 19 MPS cases, after a full clinical, radiological, and biochemical study, were classified as follows: Hurler -- MPS I (1 case); Hunter -- MPS II (2 cases); Sanfilippo -- MPS III (2 cases); Morquio -- MPS IV (4 cases); Maroteaux-Lamy -- MPS VI (9 cases); and Sly -- MPS VII (1 case). DISCUSSION: The high relative frequency of Maroteaux-Lamy disease contrasts with most reports in the literature and could express a population variability